196 related articles for article (PubMed ID: 23872350)
1. Downregulation of SnoN oncoprotein induced by antibiotics anisomycin and puromycin positively regulates transforming growth factor-β signals.
Hernández-Damián J; Tecalco-Cruz AC; Ríos-López DG; Vázquez-Victorio G; Vázquez-Macías A; Caligaris C; Sosa-Garrocho M; Flores-Pérez B; Romero-Avila M; Macías-Silva M
Biochim Biophys Acta; 2013 Nov; 1830(11):5049-58. PubMed ID: 23872350
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of Ski and SnoN co-repressors by anisomycin.
Vázquez-Macías A; Ruíz-Mendoza AB; Fonseca-Sánchez MA; Briones-Orta MA; Macías-Silva M
FEBS Lett; 2005 Jul; 579(17):3701-6. PubMed ID: 15967445
[TBL] [Abstract][Full Text] [Related]
3. Loss of c-myc repression coincides with ovarian cancer resistance to transforming growth factor beta growth arrest independent of transforming growth factor beta/Smad signaling.
Baldwin RL; Tran H; Karlan BY
Cancer Res; 2003 Mar; 63(6):1413-9. PubMed ID: 12649207
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of SnoN expression in obstructive nephropathy is mediated by an enhanced ubiquitin-dependent degradation.
Tan R; Zhang J; Tan X; Zhang X; Yang J; Liu Y
J Am Soc Nephrol; 2006 Oct; 17(10):2781-91. PubMed ID: 16959829
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of Smad transcriptional corepressors SnoN and Ski in the fibrotic kidney: an amplification mechanism for TGF-beta1 signaling.
Yang J; Zhang X; Li Y; Liu Y
J Am Soc Nephrol; 2003 Dec; 14(12):3167-77. PubMed ID: 14638915
[TBL] [Abstract][Full Text] [Related]
6. SnoN co-repressor binds and represses smad7 gene promoter.
Briones-Orta MA; Sosa-Garrocho M; Moreno-Alvarez P; Fonseca-Sánchez MA; Macías-Silva M
Biochem Biophys Res Commun; 2006 Mar; 341(3):889-94. PubMed ID: 16442497
[TBL] [Abstract][Full Text] [Related]
7. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
[TBL] [Abstract][Full Text] [Related]
8. The downregulation of SnoN expression in human renal proximal tubule epithelial cells under high-glucose conditions is mediated by an increase in Smurf2 expression through TGF-β1 signaling.
Li X; Diao Z; Ding J; Liu R; Wang L; Huang W; Liu W
Int J Mol Med; 2016 Feb; 37(2):415-22. PubMed ID: 26743567
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid remodels extracellular matrix (ECM) of cultured human fetal palate mesenchymal cells (hFPMCs) through down-regulation of TGF-β/Smad signaling.
Li X; Zhang L; Yin X; Gao Z; Zhang H; Liu X; Pan X; Li N; Yu Z
Toxicol Lett; 2014 Mar; 225(2):208-15. PubMed ID: 24374174
[TBL] [Abstract][Full Text] [Related]
10. Arkadia induces degradation of SnoN and c-Ski to enhance transforming growth factor-beta signaling.
Nagano Y; Mavrakis KJ; Lee KL; Fujii T; Koinuma D; Sase H; Yuki K; Isogaya K; Saitoh M; Imamura T; Episkopou V; Miyazono K; Miyazawa K
J Biol Chem; 2007 Jul; 282(28):20492-501. PubMed ID: 17510063
[TBL] [Abstract][Full Text] [Related]
11. Requirement for the SnoN oncoprotein in transforming growth factor beta-induced oncogenic transformation of fibroblast cells.
Zhu Q; Pearson-White S; Luo K
Mol Cell Biol; 2005 Dec; 25(24):10731-44. PubMed ID: 16314499
[TBL] [Abstract][Full Text] [Related]
12. Up-regulated transcriptional repressors SnoN and Ski bind Smad proteins to antagonize transforming growth factor-beta signals during liver regeneration.
Macias-Silva M; Li W; Leu JI; Crissey MA; Taub R
J Biol Chem; 2002 Aug; 277(32):28483-90. PubMed ID: 12023281
[TBL] [Abstract][Full Text] [Related]
13. The transforming activity of Ski and SnoN is dependent on their ability to repress the activity of Smad proteins.
He J; Tegen SB; Krawitz AR; Martin GS; Luo K
J Biol Chem; 2003 Aug; 278(33):30540-7. PubMed ID: 12764135
[TBL] [Abstract][Full Text] [Related]
14. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
Yang J; Dai C; Liu Y
J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870
[TBL] [Abstract][Full Text] [Related]
15. Actin-cytoskeleton polymerization differentially controls the stability of Ski and SnoN co-repressors in normal but not in transformed hepatocytes.
Caligaris C; Vázquez-Victorio G; Sosa-Garrocho M; Ríos-López DG; Marín-Hernández A; Macías-Silva M
Biochim Biophys Acta; 2015 Sep; 1850(9):1832-41. PubMed ID: 26002202
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin-dependent degradation of SnoN and Ski is increased in renal fibrosis induced by obstructive injury.
Fukasawa H; Yamamoto T; Togawa A; Ohashi N; Fujigaki Y; Oda T; Uchida C; Kitagawa K; Hattori T; Suzuki S; Kitagawa M; Hishida A
Kidney Int; 2006 May; 69(10):1733-40. PubMed ID: 16625151
[TBL] [Abstract][Full Text] [Related]
17. Cytoplasmic SnoN in normal tissues and nonmalignant cells antagonizes TGF-beta signaling by sequestration of the Smad proteins.
Krakowski AR; Laboureau J; Mauviel A; Bissell MJ; Luo K
Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12437-42. PubMed ID: 16109768
[TBL] [Abstract][Full Text] [Related]
18. The oncoprotein c-ski functions as a direct antagonist of the transforming growth factor-{beta} type I receptor.
Ferrand N; Atfi A; Prunier C
Cancer Res; 2010 Nov; 70(21):8457-66. PubMed ID: 20959473
[TBL] [Abstract][Full Text] [Related]
19. The phosphatidylinositol 3-kinase/Akt pathway regulates transforming growth factor-{beta} signaling by destabilizing ski and inducing Smad7.
Band AM; Björklund M; Laiho M
J Biol Chem; 2009 Dec; 284(51):35441-9. PubMed ID: 19875456
[TBL] [Abstract][Full Text] [Related]
20. Adenoviral delivery of dominant-negative transforming growth factor beta type II receptor up-regulates transcriptional repressor SKI-like oncogene, decreases matrix metalloproteinase 2 in hepatic stellate cell and prevents liver fibrosis in rats.
Marquez-Aguirre A; Sandoval-Rodriguez A; Gonzalez-Cuevas J; Bueno-Topete M; Navarro-Partida J; Arellano-Olivera I; Lucano-Landeros S; Armendariz-Borunda J
J Gene Med; 2009 Mar; 11(3):207-19. PubMed ID: 19189315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
